Note: This event was originally planned for 29-30 April, 2020 in Reykjavik, Iceland and has now been rescheduled
New date: 20-21 October, 2020
This edition will focus on improving production methods, both from an efficiency and a sustainable perspective, with case studies from key players of each segment bringing forward their experience.
The conference will also take an in-depth look into the most recently developed technologies, the potential of algae as a biomaterials, as well as the way to get algae to the next level, on a standards, awareness and marketing levels. The various conference topics will be discussed through case studies sessions and interactive panel discussions, to ensure a positive exchange with all industry actors involved.
The participants will also have the chance to discuss how to keep the industry thriving as a whole during the numerous Q&As, and the extended networking breaks.
- 10 Years Later: Throwback to the Development & Growth of the European Industry
- Determining the Most Appropriate Production Solution & its Financing
- Improving the Sustainability of Algae Production
- Navigating the Latest Technology for Algae Production
- Algae as a Biomaterial
- Food & Nutraceuticals: Practical Approaches to Using Algae
- The Benefits of Microalgae for Cosmetics
- Considering Regulations whilst Developing Products
- Getting Algae Products to the Next Level
Who will Attend
- Algae producers & cultivation plant owners and operators
- Algae end market users in nutrition, cosmetics, pigments, animal feed, bioplastics, agriculture and many more
- Leading algae/biomass research institutes, technology providers for cultivation, harvesting, dewatering, drying, oil extraction and processing
- Plant engineers and constructors, green energy & biotech investors
- Green energy/Biotechnology investors: venture capitalists, private equity firms etc. looking to invest in new & emerging markets
- Regulators & governments: organisations looking into the regulation of algae based products
Exclusive Site Visit
During the Monday 19th October afternoon, prior to the conference, a limited number of attendees will receive the unique opportunity to visit the Algalif plant.
Algalif Iceland is a commercial producer of natural products derived from microalgae. The company was founded in 2012, but began formal operations in Iceland in October 2013. The company is dedicated to solving the nutritional needs of current and future generations and currently produces high-quality astaxanthin, through cultivation of the microalgae Haematococcus pluvialis. Astalif astaxanthin was the first step in creating microalgae-derived products using an in-house designed tubular photobioreactor (PBR) cultivation system, powered by a proprietary LED lighting system. By using this production method, Algalif has set new industry benchmarks for astaxanthin production and surpassed industry-accepted maxima of astaxanthin content in algae biomass, as well as the overall process productivity. Algalif has strong ties to the pristine Icelandic nature and Algalif's products benefit from the unique environment in which they are produced. Iceland is one of the most sustainable countries in the world and the Icelandic water is extremely pure, low in minerals and unchlorinated. This is particularly important when using algae for high-value target production, due to the high biosorption capacity of algae. The country generates 100% of its electricity from clean energy, using only 35% of its estimated potential. Algalif's harvesting process is very eco-friendly; our production methods allow for close to 0% water evaporation and eliminates the need to cool, heat, or move water during our production process, allowing us to conserve water.
There is no extra charge to attend the site visit, but spaces are limited and allocated on a first come first served basis. Please register your attendance for the site visit when booking for the conference.COVID-19
We are doing everything to ensure that all our events go ahead as advertised. Like you, we are keen to get the meetings to happen and return to some form of normality. We are constantly tracking WHO updates, local government regulations and talking to our attendees wherever possible. Venues are chosen and procedures are adjusted in order to make the conferences possible.
But we do accept that these are exceptionally challenging times and the updates are very fast moving. As such, it may help you to understand how and why we arrive at decisions on moving ahead with any current event: One month before the meeting we again re-assess the situation specific to the individual summit, both local to the event and globally. We then take a decision as to the viability of holding the meeting as if it were happening the very next day. If it is possible to run on that basis, we will proceed. If not, we will be forced to take the decision to postpone the event to a later and better date.